Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vaccentis logo — VACCENTIS FOCUSES ON DEVELOPING IMMUNO-ONCOLOGY VACCINES UT...

Vaccentis

VACCENTIS FOCUSES ON DEVELOPING IMMUNO-ONCOLOGY VACCINES UTILISING ITS AUTOLOGOUS TUMOUR VACCINE TECHNOLOGY PLATFORM

Founded 2006 Switzerland Zurich, Switzerland 5 employees Health Care

General Information

Company Name Vaccentis
Founded Year 2006
Location Switzerland Zurich, Switzerland
Employees 5
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with Vaccentis. To contact Vaccentis, visit vaccentis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vaccentis compare?

A PDF of Vaccentis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vaccentis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vaccentis

Vaccentis is a health care startup with a focus on developing immuno-oncology vaccines utilizing its autologous tumor vaccine technology platform. The company was founded in 2006 and is currently in the late stage development of an autologous tumor vaccine for Renal Cell Carcinoma. Their medical division is dedicated to developing clinically proven products that have been shown to maintain remission and alleviate disease. Their flagship product, the VCC-001 cancer vaccine, has shown promising Phase III data in Renal Cell Cancer, demonstrating clinical effect and high tolerance, particularly significant as there are few current treatment options for this disease. Moreover, the VCC-001 cancer vaccine platform holds significant potential in treating metastatic renal cell, colon, and pancreatic cancers. As of now, there is no public information available about their last investment or the investors involved.

Business keywords: Immunotherapy, Cancer Vaccines, Oncology, Tumor Vaccine Technology, Autoimmune Oncology, Renal Cell Carcinoma, Metastatic Cancer Treatment, Clinical Research, Patient-Specific Medicines, Evidence-Based Medicine, Medical Product Development, Natural Medicine, Biopharmaceuticals

No funding data available for Vaccentis yet.

Vaccentis Alternatives & Competitors

View All Alternatives
Vaccentis vs
TC BioPharm
TC BioPharm United Kingdom

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

Post-IPO Equity
51 employees
Biotechnology, Health Care
Vaccentis vs
Madison Vaccines
Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their effectiven...

Venture round
Biotechnology, Health Care
Vaccentis vs
ImmunityBio, Inc.
ImmunityBio, Inc. United States

Outsmart Your Disease™

Post-IPO Debt
656 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Vaccentis

VACCENTIS FOCUSES ON DEVELOPING IMMUNO-ONCOLOGY VACCINES UTILISING ITS AUTOLOGOUS TUMOUR VACCINE TECHNOLOGY PLATFORM
Vaccentis was founded in 2006.
Vaccentis is headquartered in Zurich, Switzerland.
Vaccentis operates in Health Care. Its work centres on Immunotherapy, Cancer Vaccines, Oncology and Tumor Vaccine Technology.
Vaccentis has approximately 5 employees.
Top alternatives and competitors to Vaccentis include TC BioPharm , Madison Vaccines, ImmunityBio, Inc., EV Therapeutics, NEOGAP Therapeutics AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaccentis and TC BioPharm are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vaccentis, https://bouncewatch.com/company/vaccentis, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes